JHS Sven.Lab.

{
  "main_header": {
    "sid": 150728,
    "name": "JHS Sven.Lab.",
    "stock_name": "JHS Sven.Lab.",
    "full_name": "JHS Svendgaard Laboratories Ltd",
    "name_url": "stocks-analysis/jhs-svenlab",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "7.86",
    "chg": 0.24,
    "chgp": "3.15%",
    "dir": 1,
    "prev_price": "7.62",
    "mcapval": "70.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532771,
    "symbol": "JHS",
    "ind_name": "FMCG",
    "ind_code": 31,
    "sector_id": 29,
    "indexname": "India SENSEX",
    "isin": "INE544H01014",
    "curr_date": "Aug 07, 03:30 PM",
    "curr_time": "02:24 AM",
    "last_traded_at": "Aug 07, 03:30 PM IST",
    "bse_nse_vol": "89.9 k",
    "exc_status": "Active",
    "traded_date": "Aug 07, 2026",
    "traded_date_str": "2026 08 07",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/jhs-svenlab-150728-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "JHS Svendgaard Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jhs-svendgaard-laboratories-ltd-is-rated-strong-sell-4132315",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/JHSSvendgaardLa_mojoScore_4132315.png",
        "date": "2026-08-02 10:10:16",
        "description": "JHS Svendgaard Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 Nov 2024. However, the analysis and financial metrics discussed here reflect the company’s current position as of 02 August 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "JHS Svendgaard Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jhs-svendgaard-laboratories-ltd-is-rated-strong-sell-4112451",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/JHSSvendgaardLa_mojoScore_4112451.png",
        "date": "2026-07-21 10:10:29",
        "description": "JHS Svendgaard Laboratories Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 13 Nov 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "JHS Svendgaard Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jhs-svendgaard-laboratories-ltd-is-rated-strong-sell-4096338",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/JHSSvendgaardLa_mojoScore_4096338.png",
        "date": "2026-07-10 10:10:30",
        "description": "JHS Svendgaard Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 Nov 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below represent the company’s current position as of 10 July 2026, providing investors with the latest insights into its performance and prospects."
      },
      {
        "title": "JHS Svendgaard Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jhs-svendgaard-laboratories-ltd-is-rated-strong-sell-4076957",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/JHSSvendgaardLa_mojoScore_4076957.png",
        "date": "2026-06-29 10:10:26",
        "description": "JHS Svendgaard Laboratories Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 13 Nov 2024. However, the analysis and financial metrics presented here reflect the stock's current position as of 29 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "JHS Svendgaard Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jhs-svendgaard-laboratories-ltd-is-rated-strong-sell-4058888",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/JHSSvendgaardLa_mojoScore_4058888.png",
        "date": "2026-06-17 10:10:37",
        "description": "JHS Svendgaard Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 Nov 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 17 June 2026, providing investors with the latest insights into its performance and prospects."
      },
      {
        "title": "JHS Svendgaard Laboratories Ltd Locks at Lower Circuit With 7.41% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jhs-svendgaard-laboratories-ltd-plunges-to-lower-circuit-amid-heavy-selling-pressure-4038233",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/JHSSvendgaardLa_stocks_hitting_lower_circuit_4038233.png",
        "date": "2026-06-08 11:00:09",
        "description": "At Rs 7.90, sellers were still queuing — but there were no buyers willing to take the other side. JHS Svendgaard Laboratories Ltd locked at its lower circuit of 7.41% on 8 Jun 2026, with unfilled sell orders and a frozen price, signalling a pronounced imbalance in supply and demand."
      },
      {
        "title": "JHS Svendgaard Laboratories Ltd Gains 6.22%: 4 Key Factors Driving the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jhs-svendgaard-laboratories-ltd-gains-622-4-key-factors-driving-the-week-4024664",
        "imagepath": "",
        "date": "2026-05-31 15:02:30",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>25 May:</strong> Stock opens at Rs.8.60, modest gain amid Sensex rally</p>\n                    <p><strong>26 May:</strong> Hits upper circuit at Rs.9.08 on strong buying momentum</p>\n                    <p><strong>27 May:</strong> Reports flat quarterly performance; hits upper circuit again at Rs.9.53</p>\n                    <p><strong>29 May:</strong> Week closes at Rs.9.05, down 2.58% on last trading day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.8.60</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><d..."
      },
      {
        "title": "Are JHS Svendgaard Laboratories Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-jhs-svendgaard-laboratories-ltd-latest-results-good-or-bad-4018939",
        "imagepath": "",
        "date": "2026-05-28 19:22:00",
        "description": "JHS Svendgaard Laboratories Ltd's latest financial results for Q4 FY26 present a complex picture characterized by significant revenue growth juxtaposed with persistent operational losses. The company reported net sales of ₹32.70 crores, reflecting a notable sequential increase of 40.52% from the previous quarter and a year-on-year growth of 29.92%. This marks the highest quarterly revenue in recent history, suggesting some market traction.\n\nHowever, the company's net profit fell to a loss of ₹3.57 crores, indicating a substantial decline compared to a profit of ₹0.79 crores in the prior quarter. This represents a dramatic quarter-on-quarter deterioration of 551.90% and a year-on-year increase in losses of 48.71%. The operating margin also remained negative at -4.95%, although this is an improvement from -21.37% in Q4 FY25, highlighting ongoing operational inefficiencies that have hindered profitability desp..."
      },
      {
        "title": "JHS Svendgaard Q4 FY26: Steep Losses Overshadow Revenue Growth as Operational Challenges Mount",
        "link": "https://www.marketsmojo.com/news/result-analysis/jhs-svendgaard-q4-fy26-steep-losses-overshadow-revenue-growth-as-operational-challenges-mount-4017367",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/JHSSvendgaardLa_quaterlyResult_4017367.png",
        "date": "2026-05-27 17:45:26",
        "description": "JHS Svendgaard Laboratories Ltd., the Himachal Pradesh-based oral care products manufacturer, reported a disappointing fourth quarter for FY26, posting a net loss of ₹3.57 crores despite achieving its highest quarterly revenue in recent years. The loss widened dramatically by 551.90% quarter-on-quarter and remained 48.71% higher year-on-year, raising serious concerns about the company's operational efficiency and profitability trajectory. With a market capitalisation of just ₹83.00 crores and shares trading at ₹9.29, the stock has underperformed significantly, declining 35.49% over the past year whilst the broader market fell only 6.97%."
      }
    ],
    "total": 218,
    "sid": "150728",
    "stock_news_url": "https://www.marketsmojo.com/news/jhs-svendgaard-laboratories-150728"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Approval Of Un-Audited Financial Results For The Quarter Ended 30 June 2026",
      "datetime": "05-Aug-2026",
      "details": "JHS Svendgaard Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve Un-Audited Financial Results for the Quarter Ended 30 June 2026",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
      "datetime": "31-Jul-2026",
      "details": "Voting Results and Scrutinizer Report of Postal Ballot of the company concluded on 29 July 2026.",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot",
      "datetime": "29-Jul-2026",
      "details": "Proceedings of Postal Ballot by Remote E-Voting Process by Members of the Company concluded on July 29 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "11 Aug 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "JHS Svendgaard Laboratories Ltd has declared <strong>8%</strong> dividend, ex-date: 26 Dec 11",
          "dt": "2011-12-26",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

JHS Svendgaard Laboratories Ltd is Rated Strong Sell

2026-08-02 10:10:16

JHS Svendgaard Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 Nov 2024. However, the analysis and financial metrics discussed here reflect the company’s current position as of 02 August 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

JHS Svendgaard Laboratories Ltd is Rated Strong Sell

2026-07-21 10:10:29

JHS Svendgaard Laboratories Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 13 Nov 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

JHS Svendgaard Laboratories Ltd is Rated Strong Sell

2026-07-10 10:10:30

JHS Svendgaard Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 Nov 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below represent the company’s current position as of 10 July 2026, providing investors with the latest insights into its performance and prospects.

Read full news article

JHS Svendgaard Laboratories Ltd is Rated Strong Sell

2026-06-29 10:10:26

JHS Svendgaard Laboratories Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 13 Nov 2024. However, the analysis and financial metrics presented here reflect the stock's current position as of 29 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

JHS Svendgaard Laboratories Ltd is Rated Strong Sell

2026-06-17 10:10:37

JHS Svendgaard Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 Nov 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 17 June 2026, providing investors with the latest insights into its performance and prospects.

Read full news article

JHS Svendgaard Laboratories Ltd Locks at Lower Circuit With 7.41% Loss — Sellers Queue, No Buyers in Sight

2026-06-08 11:00:09

At Rs 7.90, sellers were still queuing — but there were no buyers willing to take the other side. JHS Svendgaard Laboratories Ltd locked at its lower circuit of 7.41% on 8 Jun 2026, with unfilled sell orders and a frozen price, signalling a pronounced imbalance in supply and demand.

Read full news article

JHS Svendgaard Laboratories Ltd Gains 6.22%: 4 Key Factors Driving the Week

2026-05-31 15:02:30

Key Events This Week

25 May: Stock opens at Rs.8.60, modest gain amid Sensex rally

26 May: Hits upper circuit at Rs.9.08 on strong buying momentum

27 May: Reports flat quarterly performance; hits upper circuit again at Rs.9.53

29 May: Week closes at Rs.9.05, down 2.58% on last trading day

Week Open

Rs.8.60

Week Close

Read full news article

Are JHS Svendgaard Laboratories Ltd latest results good or bad?

2026-05-28 19:22:00

JHS Svendgaard Laboratories Ltd's latest financial results for Q4 FY26 present a complex picture characterized by significant revenue growth juxtaposed with persistent operational losses. The company reported net sales of ₹32.70 crores, reflecting a notable sequential increase of 40.52% from the previous quarter and a year-on-year growth of 29.92%. This marks the highest quarterly revenue in recent history, suggesting some market traction. However, the company's net profit fell to a loss of ₹3.57 crores, indicating a substantial decline compared to a profit of ₹0.79 crores in the prior quarter. This represents a dramatic quarter-on-quarter deterioration of 551.90% and a year-on-year increase in losses of 48.71%. The operating margin also remained negative at -4.95%, although this is an improvement from -21.37% in Q4 FY25, highlighting ongoing operational inefficiencies that have hindered profitability desp...

Read full news article

JHS Svendgaard Q4 FY26: Steep Losses Overshadow Revenue Growth as Operational Challenges Mount

2026-05-27 17:45:26

JHS Svendgaard Laboratories Ltd., the Himachal Pradesh-based oral care products manufacturer, reported a disappointing fourth quarter for FY26, posting a net loss of ₹3.57 crores despite achieving its highest quarterly revenue in recent years. The loss widened dramatically by 551.90% quarter-on-quarter and remained 48.71% higher year-on-year, raising serious concerns about the company's operational efficiency and profitability trajectory. With a market capitalisation of just ₹83.00 crores and shares trading at ₹9.29, the stock has underperformed significantly, declining 35.49% over the past year whilst the broader market fell only 6.97%.

Read full news article

View All News